Dual targeting multiwalled carbon nanotubes for improved neratinib delivery in breast cancer-Reference-Cited by-同舟云学术

Dual targeting multiwalled carbon nanotubes for improved neratinib delivery in breast cancer

Published:2023 Issue:35 Volume:13 Page:24309-24318
ISSN:2046-2069
Container-title:RSC Advances
language:en
Short-container-title:RSC Adv.

Author:

Abu Lila Amr Selim¹²,Bhattacharya Rohini³,Moin Afrasim¹,Al Hagbani Turki¹,Abdallah Marwa Helmy¹²,Danish Rizvi Syed Mohd¹,Khafagy El-Sayed⁴⁵,Hussain Talib⁶,Gangadharappa Hosahalli Veerabhadrappa³^ORCID

Affiliation:

1. Department of Pharmaceutics, College of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia

2. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Zagazig University, Zagazig 44519, Egypt

3. Department of Pharmaceutics, JSS College of Pharmacy, JSS Academy of Higher Education and Research, Mysuru 570015, India

4. Department of Pharmaceutics, College of Pharmacy, Prince Sattam Bin Abdulaziz University, Al-kharj 11942, Saudi Arabia

5. Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Suez Canal University, Ismailia 41522, Egypt

6. Department of Pharmacology and Toxicology, College of Pharmacy, University of Ha'il, Ha'il 81442, Saudi Arabia

Abstract

The aim of this study was to develop biotinylated chitosan (Bio–Chi) decorated multi-walled carbon nanotubes (MWCNTs) for breast cancer therapy with the tyrosine kinase inhibitor, neratinib (NT).

Publisher

Royal Society of Chemistry (RSC)

Subject

General Chemical Engineering,General Chemistry

Link

http://pubs.rsc.org/en/content/articlepdf/2023/RA/D3RA04732F

Reference53 articles.

1. Folic acid-conjugated raloxifene-loaded graphene-based nanocarrier: Fabrication, characterization and antitumor screening

2. Global Trend of Breast Cancer Mortality Rate: A 25-Year Study

3. Formulation, characterization, and cellular toxicity assessment of tamoxifen-loaded silk fibroin nanoparticles in breast cancer

4. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

5. Current and future burden of breast cancer: Global statistics for 2020 and 2040

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Implications of nanotherapeutic advancements to leverage multi-drug resistant breast cancer: The state-of-the-art review;Journal of Drug Delivery Science and Technology;2024-10

2. Ligand-conjugated multiwalled carbon nanotubes for cancer targeted drug delivery;Frontiers in Pharmacology;2024-07-25